Background. The main aim of this systematic review was to assess whether remote ischaemic preconditioning (RIPC) protects kidneys and the heart in cardiac surgery with cardiopulmonary bypass (CPB) and to investigate a possible role of anaesthetic agents. Methods. Randomized clinical trials (RCTs) on the effects of RIPC through limb ischaemia in adult patients undergoing cardiac surgery with CPB were searched (1965( -October 2016 in PubMed, Cochrane Library and article reference lists. A random effects model on standardized mean difference (SMD) for continuous outcomes and the Peto odds ratio (OR) for dichotomous outcomes were used to meta-analyse data. Subgroup analyses to evaluate the effects of different anaesthetic regimens were pre-planned. Results. Thirty-three RCTs (5999 participants) were included. In the whole group, RIPC did not significantly reduce the incidence of acute kidney injury (AKI), acute myocardial infarction, atrial fibrillation, mortality or length of intensive care unit (ICU) and hospital stays. On the contrary, RIPC significantly reduced the area under the curve for myocardial injury biomarkers (MIBs) {SMD À0.37 [95% confidence interval (CI) À0.53 to À 0.21]} and the composite endpoint incidence [OR 0.85 (95% CI 0.74-
0.97)]. In the volatile anaesthetic group, RIPC significantly reduced AKI incidence [OR 0.57 (95% CI 0.41-0.79)] and marginally reduced ICU stay. Conversely, except for MIBs, RIPC had fewer non-significant effects under propofol with or without volatile anaesthetics.
Conclusions. RIPC did not consistently reduce morbidity and mortality in adults undergoing cardiac surgery with CPB. In the subgroup on volatile anaesthetics only, RIPC markedly and significantly reduced the incidence of AKI and composite endpoint as well as myocardial injury.
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Cardiac interventions are a frequent cause of acute kidney injury (AKI) [1] associated with increased morbidity and mortality and prolonged intensive care unit (ICU) and hospital stays [1] . Moreover, acute myocardial infarction (AMI) and atrial fibrillation (AF) represent another important postoperative complication, since their incidences are 5-10% and 20-30%, respectively [2] [3] [4] . Hence, strategies aimed at increasing both renal and myocardial tolerance to sustained ischaemia are needed. In remote ischaemic preconditioning (RIPC), a brief, repeated, mild ischaemia-reperfusion to one organ protects another organ from a subsequent episode of lethal ischaemiareperfusion. The RIPC stimulus may reach the target through neurogenic pathways, humoral mediators or changes in circulating leucocytes and platelets [5, 6] .
The most significant clinical observation has been that brief periods of limb ischaemia (via blood pressure cuff) followed by reperfusion protect the heart and kidneys [2, [5] [6] [7] [8] , even though these findings have been recently challenged by two large randomized clinical trials (RCTs) [3, 4] . Moreover, many studies have insufficient statistical power and many confounding factors have been claimed, including anaesthetic regimens [9] [10] [11] [12] [13] [14] . Finally, most meta-analyses on RIPC in cardiovascular interventions published since 2012 have included papers on different kinds of cardiovascular surgery and percutaneous cardiac interventions (PCIs) with different RIPC protocols in both adult and pediatric patients . Such wide heterogeneity may cause different renal and cardiac risks owing to differences in the risk of organ ischaemia (duration, weight of interventions, etc.) and related tolerance (e.g. pediatric versus adult surgery).
For the above-mentioned reasons, we planned to conduct this updated systematic review and meta-analysis of RCTs to reassess the renal and cardiac protection achieved by RIPC in adults undergoing cardiac surgery with cardiopulmonary bypass (CPB) and to evaluate the effects of different anaesthetic regimens.
M A T E R I A L S A N D M E T H O D S
This systematic review and meta-analysis was conducted according to Guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analysis [39] and followed a prespecified but not registered protocol.
Eligibility criteria
Inclusion criteria were adults (>18 years old) undergoing cardiac surgery with CPB and RIPC or sham RIPC. Exclusion criteria were non-human studies, paediatric patients, nonpertinent surgical and/or ischaemic conditioning protocols and absence of information on predefined outcomes. Reviews, editorials, conference articles, comments, letters, abstracts only, substudies, protocols and non-RCTs were also excluded.
Outcome measures
Studies had to report at least one of the following short-term outcomes:
• • Secondary outcomes: 1. AMI, by using investigator definitions; 2. AF; 3. length of ICU or hospital stays (see Supplementary data, Appendix 1); 4. postoperative mortality; 5. a composite endpoint (AKI, RRT, short-term AMI and mortality) was subsequently defined and used as a secondary outcome.
Search strategy
The PubMed (US National Library of Medicine, Bethesda, MD, USA; from 1965 to 14 October 2016) and Cochrane databases (with the same time limits) were searched without language restriction.
One author (G.D.) performed the search using the following search string: (remote ischaemic preconditioning OR RIPC) AND [(cardiac surgery AND (cardiopulmonary bypass OR CPB)] OR cardiac protection OR renal protection OR myocardial injury OR acute kidney injury OR acute renal failure OR acute myocardial infarction OR atrial fibrillation OR mortality). For PubMed, the 'humans' filter was set.
Bibliographies of retrieved articles, review articles and metaanalyses were also consulted for potential references.
Study selection and data extraction
Two reviewers (A.B., G.D.) independently screened titles and abstracts and included full-text trials according to inclusion criteria. Disagreements between the two reviewers concerning whether to include a study were resolved by discussion. The corresponding author was asked to provide via e-mail relevant information regarding single-study unpublished data.
Quality assessment and risk of bias
Two reviewers (A.B., C.A.) independently assessed the quality of included studies and risk of bias according to the Cochrane criteria [43] consisting of (i) random sequence generation and allocation concealment (selection bias), (ii) blinding of participants and personnel (performance bias) and outcome assessment (detection bias), (iii) incomplete outcome data (attrition bias) and (iv) selective reporting (reporting bias). Differences between reviewer's opinions were resolved by discussion with an arbiter (A.S.).
Data synthesis and analysis
For each trial, the number of patients with the relevant outcomes and those included for each study group was extracted and the logarithm of odds ratios (ORs) with the associated 95% confidence interval (CI) for each categorical outcome were calculated. Standardized mean difference (SMD) and the associated 95% CI were calculated for continuous outcomes; for this purpose, means and SDs were extracted; if an SEM was reported, SD was calculated by multiplying SEM by the square root of the sample size. In case of non-availability of mean and SD, the following mathematical approximation methods were used as a replacement, depending on available data: geometric mean transformation, mean SD approximation from medians and interquartile ranges [43] .
Statistical heterogeneity across trials was assessed by means of the Cochrane Q test and I 2 values were reported. A random effects model was used to obtain the pooled estimates of SMD. The low rate of events in almost all outcomes and the absence of any substantial imbalance between treatment and control group sizes within studies suggested instead the use of the Peto method to pool ORs. To evaluate effects of different anaesthetic regimens, we performed a subgroup analysis according to anaesthetics used for maintenance anaesthesia. We analysed results as a pool and according to anaesthetics for maintenance.
A sensitivity analysis performed by removing studies with extreme results was pre-planned. A weighted random effects meta-regression analysis was used to test the influence of patients' demographic and clinical characteristics, including surgery, on the relationship between RIPC and outcomes in the whole group and in the anaesthetic subgroups. Predictors with a P-value <0.10 in univariable analysis were considered in the multivariable meta-regression model.
Funnel plots were realized to evaluate publication bias and the Egger test was reported to statistically test the funnel plot asymmetry.
Data analysis was performed using STATA 13.0 (StataCorp, College Station, TX, USA).
R E S U L T S

Study selection and characteristics
The study selection process is presented in Supplementary data, Figure 1S . The search strategy identified 535 potentially relevant articles. By analysing titles and abstracts, 490 articles were excluded for not meeting inclusion criteria. After a detailed reading of each full text, a further 12 articles were excluded. Finally, 36 studies reported in 33 full-text articles were included [2-4, 7-10, 44-69] ; three of them [9, 52, 63] were divided into two studies because of different design.
Study characteristics are summarized in Table 1 . A total of 5999 participants were enrolled, 2999 randomized to RIPC and 3000 to sham RIPC. Baseline characteristics of patients were comparable between RIPC and controls. In all studies, patients with CKD Stages 4 and 5 were excluded. In 18 studies, !80% of patients underwent isolated CABG; in 8 studies, most patients had isolated valve surgery; and in 10 studies, patients underwent concomitant surgery. As for anaesthesia maintenance, volatile agents alone were used in 16 studies in all or nearly all patients and propofol with or without volatile agents was used in 16 studies (6 propofol only and 10 propofol and volatile agents). Studies that used propofol alone or propofol and volatile agents are presented as a unique subgroup, as we found no significant differences among them for evaluated outcomes. In two studies, neither volatile agents nor propofol were used [52] , while one study used 'general anaesthesia' [48] ; in another study, volatile agents or propofol were used in 50% of patients [50] . These four studies were included in the 'other anaesthetics' subgroup (228 patients). Preoperative RIPC was carried out by an inflatable cuff around the upper or lower limb (three to four cycles of !4 min); in two studies, a cuff was applied to both the upper and lower limb [52, 65] . The cuff was inflated to !200 mmHg except in two studies in which pressure was increased by 40-50 mmHg over the patient's systolic blood pressure (SBP) [63, 64] .
Risk of bias within studies
Most of the included studies resulted in a 'low' risk of bias for almost all items investigated. Only in case of allocation concealments was the judgement result 'unclear' since methods to protect against bias were not sufficiently reported (Supplementary data, Figures 2S and 3S ).
Effect of RIPC on outcomes AKI. AKI incidence was reported in 13 studies totaling 4546 patients [3, 4, 7, 8, 46, 47, 51, 58, 59, 64, 65, 68, 69] and occurred in 1145 (25.2%) patients ( Figure 1A ). The incidence of AKI was reduced, but without statistical significance, in the RIPC group Visual inspection of the funnel plot did not suggest the presence of a publication bias (Supplementary data, Figure 4S ; Egger's test; P ¼ 0.17). From meta-regression analysis, no demographic or clinical characteristics appeared to be significantly associated with this outcome.
Severe AKI. Severe AKI incidence was reported in 15 studies totalling 4564 patients [3, 4, 7, 8, 46, 47, 50, 51, 56-58, 64, 65, 68, 69] and occurred in 121 (2.6%) patients ( Figure 1B ). There was no significant difference in the incidence of severe AKI in the RIPC group compared with the control group [OR 0.83 (95% CI 0.58-1.20)], with 48.7% heterogeneity. In subgroup analysis, no statistically significant difference was observed, even though the reduction of severe AKI appeared greater in Visual inspection of the funnel plot did not suggest the presence of a publication bias (Supplementary data, Figure 5S ; Egger's test; P ¼ 0.59). From meta-regression analysis, no demographic or clinical characteristics appeared to be significantly associated with this outcome.
MIB. Thirty studies (5350 patients) reported the effect of RIPC on MIB [2-4, 9, 10, 44, 45, 47-57, 59-65, 68, 69] recorded for 72 h in 18 studies, 48 h in 9 studies and 24 h in 3 studies; 26 studies reported the AUC for troponin and 4 studies for CK-MB (Figure 2) . RIPC significantly reduced MIB in the whole group [SMD À0.37 (95% CI À0.53 to À 0.21)], with high heterogeneity (I 2 ¼ 83.6%). In subgroup analysis, a greater effect was obtained in studies under volatile anaesthesia [SMD À0.55 (95% CI À0.91 to À0.18)], whereas RIPC effects were smaller, though significant, in studies under propofol 6 volatile agents [SMD À0.14 (95% CI À0.29 to À 0.00)]. The difference between these two subgroups was not statistically significant (P ¼ 0.13). In sensitivity analysis, results were similar after removing the most optimistic studies [51] [52] [53] .
Visual inspection of the funnel plot suggested the presence of a publication bias (Supplementary data, Figure 6S ; Egger's test; P ¼ 0.014). However, studies causing asymmetry were those removed in the above-mentioned sensitivity analysis. From metaregression analysis, no demographic or clinical characteristics appeared to be significantly associated with this outcome. Postoperative mortality. Post-operative short-term mortality data were available from 23 studies in which 115 deaths were registered among 5004 patients (2.3%) [2-4, 7, 8, 9, 47, 49- 
D I S C U S S I O N
In this meta-analysis, RIPC reduced only marginally and not significantly the incidence of AKI (À13%) and severe AKI (À17%) in the whole group of studies, in line with results of most previous meta-analyses [21, 23, 24-26, 32-36, 38] ; as for meta-analyses reporting a significant AKI reduction [29] [30] [31] 37] , most of these included studies on vascular or pediatric surgery and PCI (for a weight of up to 48%).
Our meta-analysis shows that RIPC reduced the postoperative increase of MIB in the whole group, confirming and updating results of previous similar meta-analyses reporting MIB AUCs [15, 20, 23] . Many other meta-analyses either analysed peak values instead of AUC or included studies heterogeneous for interventions and patients [15-17, 20, 23, 26-28] . High levels of MIB are associated with short-and long-term outcomes after cardiac surgery [70, 71] , thus underlining a prognostic role of RIPC effects.
We also examined RIPC effects on the short-term incidence of relevant cardiac clinical outcomes, such as AMI and AF, and mortality. In the whole group, RIPC did not significantly change AMI, AF and mortality incidence, confirming most previous meta-analyses [20, 22-24, 26-30, 35, 36, 38] . Two meta-analyses showed a significant reduction in AMI [16, 17] ; however, these works were not comparable with ours, for the reasons stated above.
An important result in the whole group of studies was that RIPC significantly reduced the incidence of the composite endpoint containing major clinical outcomes, namely RRT, severe AKI, AMI and mortality. A recent meta-analysis including aortic surgery obtained similar results [32] .
The most interesting finding of our meta-analysis is that RIPC significantly reduced AKI risk by $40% AKI risk in studies using only volatile agents for anaesthesia maintenance, whereas it is inefficacious in studies on propofol with or without volatile agents. A similar result has been recently reported [38] . Interestingly, in patients on volatile anaesthesia, RIPC markedly, though not significantly, reduced in incidence of severe AKI (about À40%), a result that may be clinically important.
Importantly, under volatile anaesthetics, RIPC might also have a cardioprotective effect. In fact, AMI, in accordance with results on MIB, was markedly, though not significantly, reduced (about À40%) in the volatile group, as recently suggested [32] . Such a reduction could have important clinical repercussions and this view is substantiated by data showing a marked reduction by RIPC in the long-term incidence of AMI in patients undergoing CABG on pump under volatile agents [2] . Again, in an analogous setting, RIPC conferred a long-term improvement of New York Heart Association class and left ventricular ejection fraction [55] . In contrast, in a recent large study under propofol with or without volatile agents, RIPC induced only trivial results [3] .
Moreover, in patients under volatile anaesthetics, RIPC tended to reduce mortality, though not significantly, by $30%. This finding is in keeping with the reduction of 1-year mortality obtained in patients undergoing CABG on pump under volatile agents [2] in contrast with results obtained under propofol with or without volatile agents [3] . However, it is worth noting that many studies reported very low mortality incidence and short follow-up.
Finally, it is noteworthy that in studies not using propofol for anaesthesia maintenance, RIPC halved the incidence of RCTs on effects of RIPC the composite endpoint combining major clinical outcomes, whereas in studies using propofol, RIPC appeared ineffective.
It has been shown since 2012 that propofol, in contrast with volatile agents, abrogates the protection conferred by RIPC [9] , as recently underlined by others [11] [12] [13] . Moreover, cardiac and renal protection by propofol against ischaemia-reperfusion injury in cardiac surgery has been claimed in both animals and humans [72] [73] [74] . Therefore, another possible explanation for reduced RIPC effects in patients under propofol anaesthesia is that the mechanism of organ protection conferred by RIPC and propofol should be similar, hence minimizing the difference between RIPC and sham RIPC. Unfortunately, these data and comments were not available during the design phase of the two major trials on RIPC under propofol with or without volatile agents [3, 4] . However, it is now possible to conclude, from results of the last two trials, together with those of the largest trial on volatile anaesthetics [8] and that of our meta-analysis, that RIPC should not be performed in adult patients undergoing cardiac surgery with CPB and anaesthetized with propofol, because of the lack of demonstrable benefits.
The present meta-analysis has several strengths. First, in contrast with previous works, only studies on the effect of RIPC in a relatively homogeneous setting of cardiac surgery and RIPC protocols with comparable renal and cardiac risk were considered; moreover, the selected setting represents 70-75% of cardiac surgery interventions [75] . Second, the inclusion of studies published up to 2016 allowed us to obtain 36 studies (5999 patients), to perform subgroup analysis and meta-regression and to show the best current evidence on this topic. Third, the methodology was particularly accurate: contacts with authors when necessary, no language limitations, exclusion of outcomes using postoperative creatinine peaks (because of lack of preoperative values) or individual levels of MIB and the use of sensitivity analysis. Fourth, the authors used a composite endpoint that provided wider information on the effects of treatment since not all studies reported results of all outcomes.
This meta-analysis also has some limitations. First, the included RCTs obtained few events for some outcomes. Second, despite the homogeneity of surgical and RIPC protocols and the negative results of meta-regression, with the exception of the type of anaesthesia, interference of other variables with outcomes could not be excluded. Third, although 11 studies out of 13 used well-accepted AKI definitions, 2 studies used different, though substantially comparable definitions [47, 64] . Fourth, regarding 2 papers [47, 55] , we received no author reply, so the anaesthetic protocol remains unclear, while in 4 papers [2, 45, 46, 64] out of 16 on volatile agents, the anaesthetic procedure was followed only in the majority of patients ($75% on average).
C O N C L U S I O N S
In the whole group of studies on adults undergoing cardiac surgery with CPB, RIPC significantly reduced both MIB and the composite endpoint.
In patients on volatile agents for anaesthesia maintenance, RIPC significantly reduced AKI incidence, MIB and ICU stay. Nonetheless, the great, although not significant, effects on severe AKI, AMI and mortality should be underlined. All the above-mentioned results are confirmed and strengthened by significant effects of RIPC on the composite endpoint.
In patients anaesthetized with propofol with or without volatile agents, RIPC had no significant effects except for MIB. The difference between the two subgroups of anaesthetics was statistically substantiated for both AKI and the composite endpoint.
In summary, RIPC protects the kidney and also the heart mainly in patients anaesthetized with volatile agents. Adequately powered large RCTs examining RIPC effects on clinical outcomes in patients undergoing cardiac surgery anaesthetized with volatile agents versus propofol are urgently needed to conclusively demonstrate the protective effects of RIPC and to elucidate its molecular mechanisms.
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